Purchases and Sales Made in Q4 2023 in Ab Cellera Biologics Inc. (ABCL)
This table provides information about the institutional ownership of Ab Cellera Biologics Inc. (ABCL) during Q4 2023. The information is specifically focused on institutions that hold shares of AbCellera Biologics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-128K- 10.71% |
$501K - $760K
|
1.07M
$3.15M
|
|
|
Jan 31, 2024
Q4 2023
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-137K- 4.2% |
$534K - $810K
|
3.12M
$9.2M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-171K- 22.86% |
$670K - $1.02M
|
578K
$1.71M
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-175K- 31.74% |
$685K - $1.04M
|
377K
$1.11M
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-205K- 35.18% |
$800K - $1.21M
|
377K
$1.11M
|
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-233K- 13.74% |
$909K - $1.38M
|
1.46M
$4.31M
|
|
|
Feb 14, 2024
Q4 2023
|
Dark Forest Capital Management LP
Weston, CT |
SELL
|
- |
-268K- 96.23% |
$1.05M - $1.59M
|
10.5K
$30.9K
|
|
|
Feb 14, 2024
Q4 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-405K- 92.96% |
$1.58M - $2.4M
|
30.6K
$90.4K
|
|
|
Feb 14, 2024
Q4 2023
|
Prosight Management, LP
Dallas, TX |
SELL
|
- |
-746K- 30.5% |
$2.92M - $4.42M
|
1.7M
$5.02M
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-2.01M- 61.59% |
$7.87M - $11.9M
|
1.26M
$3.7M
|
|
|
Jan 26, 2024
Q4 2023
|
Baillie Gifford & CO
|
SELL
|
- |
-2.16M- 8.24% |
$8.45M - $12.8M
|
24M
$70.9M
|